CLIFTON R. LADUANE (CFO, Secretary & Treasurer) purchased 7.3% of their position (635.00 shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $3.7K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 1/13/2023ACC: 0001437749-23-001060
Officer· CFO, Secretary & Treasurer
Since Oct 2018
+635.00
Net shares
Net buyer
$3.7K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
635.00 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+610.00
Price / share
$5.82
Trade value
$3.55K
% of position
7.1%
1/13/2023
8.64K→9.25K
Common Stock
Direct
Shares
+25.00
Price / share
$5.58
Trade value
$139.63
% of position
0.3%
1/13/2023
9.25K→9.28K
Total
Net shares
+635.00
Net value
$3.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2023 | P · Purchase | +610.00 | $5.82 | $3.55K | 7.1% | 8.64K | 9.25K |
| Common Stock Direct | 1/13/2023 | P · Purchase | +25.00 | $5.58 | $139.63 | 0.3% | 9.25K | 9.28K |
| Total | +635.00 | $3.69K | ||||||
Derivative Transactions0
No derivative transactions reported